Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The dopamine transporter: characterization and physiopathologic implications]

F Thibaut1, J M Vaugeois, M Petit

  • 1Groupe de recherche sur la schizophrénie, Service Hospitalo-Universitaire, Scotteville-les-Rouen.

L'Encephale
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficient room-temperature synthesis of crosslinked polyhydroxyurethanes from 5-membered cyclic carbonates without solvent or catalyst.

Faraday discussions·2025
Same author

Experimental validation in a neutron exposure frame of the MINAS TIRITH for cell damage simulation.

Physics in medicine and biology·2023
Same author

[Design, implementation and evaluation of an educational approach for patients with PICC line and midline].

Annales pharmaceutiques francaises·2023
Same author

MINAS TIRITH: a new tool for simulating radiation-induced DNA damage at the cell population level.

Physics in medicine and biology·2023
Same author

Chemical sex (chemsex) in a population of French university students.

Dialogues in clinical neuroscience·2022
Same author

Antipsychotic drug dose in real-life settings results from a Nationwide Cohort Study.

European archives of psychiatry and clinical neuroscience·2021
Same journal

Measuring antidepressant side effects in military personnel - Clinical validation of the French version of the UKU-SERS-Pat Scale: A comparative study of patient and clinician ratings.

L'Encephale·2026
Same journal

[Empowerment in addictology].

L'Encephale·2026
Same journal

Evaluation of the links between smoking and conspiracy mentality.

L'Encephale·2026
Same journal

Use of a relevance assessment tool in therapeutic residential care: A real world study.

L'Encephale·2026
Same journal

Prevalence and characteristics of domestic violence in a sample of adult psychiatric outpatients: A cross-sectional study.

L'Encephale·2026
Same journal

From representations to practice: how professionals describe supporting parents with psychiatric or somatic illness or disability.

L'Encephale·2026
See all related articles

The dopamine transporter (DAT) regulates dopamine neurotransmission and is a key marker for brain disorders. DAT binding studies help understand diseases like Parkinson's, schizophrenia, and addiction.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Context:

  • The dopamine transporter (DAT) is crucial for regulating dopamine (DA) levels in the synapse.
  • DAT function is implicated in various neuropsychiatric disorders, including Parkinson's disease, schizophrenia, and cocaine addiction.
  • DAT binding assays, both in vivo and in vitro, serve as vital presynaptic markers.

Purpose:

  • To explore the role of the dopamine transporter (DAT) as a biomarker in neuropsychiatric diseases.
  • To investigate how DAT alterations contribute to the pathophysiology of Parkinson's disease, cocaine addiction, and schizophrenia.
  • To evaluate the potential of DAT as a therapeutic target.

Summary:

  • DAT regulates dopamine neurotransmission by reuptaking dopamine from the synapse.

Related Experiment Videos

  • Reduced DAT binding is observed in Parkinson's disease, potentially indicating dopaminergic neuron loss.
  • DAT is implicated in cocaine addiction and may play a role in schizophrenia, with the DAT gene being a candidate for these conditions.

    • Impact:

    • DAT imaging provides insights into dopaminergic deficits in neurodegenerative and psychiatric conditions.
    • Understanding DAT mechanisms can lead to targeted treatments for addiction and neurological disorders.
    • The DAT gene's potential role highlights avenues for future genetic research in psychiatric diseases.